SYSTEMATIC LITERATURE REVIEW OF THE EFFICACY AND SAFETY OF PHARMACOLOGICAL TREATMENTS AND SEPTAL REDUCTION THERAPIES FOR OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY

被引：0
|
作者：
Spoorendonk, J. A. [1 ]
Sahbaz Gulser, S. [1 ]
Arca, E. [1 ]
Hurst, M. [2 ]
Zema, C. [3 ]
Contente, M. [2 ]
Krause, T. [2 ]
机构：
[1] OPEN Hlth, Rotterdam, Netherlands
[2] Bristol Myers Squibb, Uxbridge, Middx, England
[3] Bristol Myers Squibb, Lawrenceville, NJ USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
MSR97
引用
收藏
页码：S368 / S368
页数：1
相关论文
共 50 条
  • [41] EFFICACY OF MAVACAMTEN IN HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Naveed, Hamza
    Aimen, Shafi Q.
    Javeed, Zainab
    Naeem, Minahil
    Ali, Shafaqat
    Basit, Jawad
    Alam, Mahboob
    Hamza, Mohammad
    Almas, Talal
    Sattar, Yasar
    Alraies, M. Chadi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 548 - 548
  • [42] COVID-19 Impacted Septal Reduction Therapies in Hypertrophic Cardiomyopathy
    Desai, Spandan
    Roma, Nicholas
    Pattoli, Megan
    Durkin, Matthew
    Shah, Kashyap
    Amaratunga, Eluwana
    Magid, Lindsey
    Yellapu, Vikas
    Shirani, Jamshid
    CIRCULATION, 2024, 150
  • [43] Septal Reduction Therapy for Obstructive Hypertrophic Cardiomyopathy: Volume Still Matters for Septal Myectomy
    See, Vincent Y. Y.
    Wang, Libin
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (10):
  • [44] Associations between procedural volume, costs, and outcomes of septal reduction therapies for obstructive hypertrophic cardiomyopathy in US hospitals
    Hernandez, Ervant J. Maksabedian
    Krishnaswami, Shanthi
    Dubey, Anandkumar
    Singh, Nisha
    Jonkman, Anna G.
    Cao, Zhun
    Tyagi, Manu
    Lipkin, Craig
    Wang, Andrew
    JOURNAL OF MEDICAL ECONOMICS, 2025, 28 (01) : 302 - 313
  • [45] A novel hybrid approach to nonsurgical septal reduction in hypertrophic obstructive cardiomyopathy
    Bezgin, Tahir
    Celik, Aziz Inan
    Baytugan, Nart Zafer
    Cagdas, Metin
    POLISH HEART JOURNAL-KARDIOLOGIA POLSKA, 2024, 82 (10): : 1013 - 1014
  • [46] Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy
    Lakkis, NM
    Nagueh, SF
    Kleiman, NS
    Killip, D
    He, ZX
    Verani, MS
    Roberts, R
    Spencer, WH
    CIRCULATION, 1998, 98 (17) : 1750 - 1755
  • [47] Long-term outcomes of septal reduction for obstructive hypertrophic cardiomyopathy
    Sedehi, Daniel
    Finocchiaro, Gherardo
    Tibayan, Yen
    Chi, Jeffrey
    Pavlovic, Aleksandra
    Kim, Young M.
    Tibayan, Frederick A.
    Reitz, Bruce A.
    Robbins, Robert C.
    Woo, Joseph
    Ha, Richard
    Lee, David P.
    Ashley, Euan A.
    JOURNAL OF CARDIOLOGY, 2015, 66 (1-2) : 57 - 62
  • [48] Electrophysiologic consequences of nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy
    不详
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2000, 11 (11) : 1296 - 1296
  • [49] Efficacy and safety of endocardial radiofrequency catheter ablation of interventricular septal hypertrophy in the treatment of hypertrophic obstructive cardiomyopathy
    Dolezalova, Katarina
    Lehar, Frantisek
    Jez, Jiri
    Pesl, Martin
    Soucek, Filip
    Starek, Zdenek
    COR ET VASA, 2022, 64 (01) : 53 - 59
  • [50] Efficacy and safety of alcohol septal ablation in patients over 65 years old with obstructive hypertrophic cardiomyopathy
    Cheddadi, Laila
    Lairez, Olivier
    Lhermusier, Thibault
    Campelo-Parada, Francisco
    Galinier, Michel
    Carrie, Didier
    Boudou, Nicolas
    CLINICAL INTERVENTIONS IN AGING, 2017, 12 : 467 - 473
12345